| DRUG WATCH |
|
| Year : 2017 | Volume
: 49
| Issue : 3 | Page : 254-256 |
Topiramate-induced acute liver injury: A rare adverse effect
Archish Khivsara1, Jeffrey Pradeep Raj2, Divya Hegde1, Mangala Rao2
1 Department of Psychiatry, St. John's Medical College, Bengaluru, Karnataka, India
2 Department of Pharmacology, St. John's Medical College, Bengaluru, Karnataka, India
Correspondence Address:
Mangala Rao
Department of Pharmacology, St. John's Medical College Bengaluru - 560 034, Karnataka
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijp.IJP_414_16
Idiosyncratic drug-induced liver injury (DILI) is damage to liver occurring at recommended dose of a drug in contrast to toxic or predictable DILI. Although it is common in first-generation antiepileptic drugs (AEDs), it is rare in newer AEDs such as topiramate. Topiramate commonly causes neurological adverse effects such as psychomotor slowing and somnolence. Hepatotoxicity by topiramate is rare and has been previously reported in combination with other drugs such as valproate and carbamazepine. Here, we report a case of topiramate-induced asymptomatic elevation of liver enzymes in an adult man diagnosed with alcohol dependence syndrome and alcohol withdrawal complicated with seizures.
[FULL TEXT] [PDF]*
|
